奥姆尼艾比生物 OABI
$5.03 +$0.20 (+4.14%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $5.02 -0.20%
开盘$4.86
昨收$4.83
当日区间$4.86 – $5.22
成交量1.44M
市值$733.68M
市盈率（TTM）–
股息率–
财报
财报日平均波动±8.4%近15次财报
收涨次数4 / 1527% 的概率
最佳反应+37.5%
最差反应-20.4%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 30 Oct 2026 | Pre Market | ±18.5% | -2.29% | 符合区间 |
| 2026/Q2 | 6 Aug 2026 | After Market | ±37.1% | +37.50% | 超出定价预期 |
| 2026/Q1 | 7 May 2026 | After Market | – | +12.93% | – |
| 2025/Q4 | 4 Mar 2026 | After Market | – | +10.50% | – |
| 2025/Q3 | 4 Nov 2025 | After Market | ±67.6% | -3.72% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | – | -2.59% | – |
| 2025/Q1 | 8 May 2025 | After Market | ±76.4% | -8.28% | 符合区间 |
| 2024/Q4 | 18 Mar 2025 | After Market | ±24.5% | -20.38% | 符合区间 |
| 2024/Q3 | 12 Nov 2024 | After Market | – | -9.35% | – |
| 2024/Q2 | 8 Aug 2024 | After Market | ±11.7% | -1.17% | 符合区间 |
| 2024/Q1 | 9 May 2024 | After Market | ±12.0% | +2.41% | 符合区间 |
| 2023/Q4 | 20 Mar 2024 | After Market | ±29.6% | -5.17% | 符合区间 |
| 2023/Q3 | 9 Nov 2023 | None | ±13.3% | -2.75% | 符合区间 |
| 2023/Q2 | 10 Aug 2023 | After Market | ±13.0% | -5.54% | 符合区间 |
| 2023/Q1 | 11 May 2023 | Pre Market | ±53.0% | -2.12% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q3, ended Sep 2026
营收$3.99M+78.3% YoY
营业利润-$16.37M+9.8% YoY
净利润-$15.73M+4.8% YoY
摊薄每股收益-$0.12+14.3% YoY
自由现金流$10.58M+206.3% YoY
经营现金流$10.58M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率97.7%
营业利润率-115.9%
净利率-108.1%
净资产收益率-16.5%
资产收益率-14.5%
投入资本回报率-16.3%
流动比率4.21
负债/资产比率14.4%
现金及投资$64.21M
总负债$14.13M
净现金（净负债）$50.08M
自由现金流/营收5.9%
暂无评论——快来第一个聊聊 OABI。
登录后参与讨论。